Cat.#: ACPP-1666
| Despition | LGALS3 Human Recombinant, His Tag |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1223 | PAX8 Blocking Peptide (AC1223) | 250 µg | inquiry |
| ACPP-1562 | Human TAGLN3 Protein (AC1562) | 5 µg | inquiry |
| ACPP-1338 | Dopamine Receptor D1 Blocking Peptide (AC1338) | 250 µg | inquiry |
| ACPP-1017 | Recombinant Human FGF19 Protein (AC1017) | 50 µg | inquiry |
| ACPP-1006 | Recombinant Human TNF Receptor II Protein (6×His Tag) (AC1006) | 50 µg | inquiry |
| ACPP-1161 | Recombinant Human DLK-1 Protein (6×His Tag) (AC1161) | 50 µg | inquiry |
| ACPP-1685 | Human MOG Protein (AC1685) | 10 µg | inquiry |
| ACPP-1322 | TRPM8 Blocking Peptide (AC1322) | 250 µg | inquiry |
| ACPP-1261 | TSH beta Blocking Peptide (AC1261) | 250 µg | inquiry |
| ACPP-1581 | Rat FGF 9 Protein (AC1581) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.